Patents by Inventor Andrew J. L. Walsh

Andrew J. L. Walsh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric natriuretic peptide compositions and methods of preparation
    Patent number: 9623085
    Abstract: Therapeutic compositions containing chimeric natriuretic peptides for treating chronic kidney disease alone, heart failure alone, or chronic kidney disease with concomitant heart failure are described. The therapeutic compositions have enhanced stability characteristics to facilitate storage and delivery by provisioning apparatuses under conditions of elevated temperature and mechanical stress. Methods for increasing the stability of therapeutic compositions containing chimeric natriuretic peptides are further described.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: April 18, 2017
    Assignee: Capricor Therapeutics, Inc.
    Inventors: William Van Antwerp, Andrew J. L. Walsh, Lian Luo, Dianne L. Judd
  • Therapy for kidney disease and/or heart failure
    Patent number: 9616107
    Abstract: Medical systems and methods for treating kidney disease alone, heart failure alone, chronic kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a natriuretic peptide such as Vessel Dilator to a subject. Methods for increasing and maintaining peptide levels at a certain concentration include direct peptide delivery via either an external or implantable programmable pump.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 11, 2017
    Assignee: Capricor Therapeutics, Inc.
    Inventors: William P. VanAntwerp, Andrew J. L. Walsh, VenKatesh R. Manda, John Burnes
  • SYSTEMS AND METHODS FOR THERAPY OF KIDNEY DISEASE AND/OR HEART FAILURE USING CHIMERIC NATRIURETIC PEPTIDES
    Publication number: 20160324930
    Abstract: Medical systems and methods for treating kidney disease alone, heart failure alone, kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a chimeric natriuretic peptide to a patient. Methods for increasing peptide levels include direct peptide delivery via either an external or implantable programmable pump.
    Type: Application
    Filed: March 14, 2016
    Publication date: November 10, 2016
    Inventors: William P. Van Antwerp, VenKatesh R. Manda, Andrew J. L. Walsh, John Burns, Daron Evans, Hsiao Lieu
  • Chimeric Natriuretic Peptide Compositions and Methods of Preparation
    Publication number: 20160051632
    Abstract: Therapeutic compositions containing chimeric natriuretic peptides for treating chronic kidney disease alone, heart failure alone, or chronic kidney disease with concomitant heart failure are described. The therapeutic compositions have enhanced stability characteristics to facilitate storage and delivery by provisioning apparatuses under conditions of elevated temperature and mechanical stress. Methods for increasing the stability of therapeutic compositions containing chimeric natriuretic peptides are further described.
    Type: Application
    Filed: November 6, 2015
    Publication date: February 25, 2016
    Applicant: CAPRICOR THERAPEUTICS, INC.
    Inventors: William Van Antwerp, Andrew J. L. Walsh, Lian Luo, Dianne L. Judd
  • THERAPY FOR KIDNEY DISEASE AND/OR HEART FAILURE
    Publication number: 20150190473
    Abstract: Medical systems and methods for treating kidney disease alone, heart failure alone, chronic kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a natriuretic peptide such as Vessel Dilator to a subject. Methods for increasing and maintaining peptide levels at a certain concentration include direct peptide delivery via either an external or implantable programmable pump.
    Type: Application
    Filed: November 26, 2014
    Publication date: July 9, 2015
    Inventors: William P. VanAntwerp, Andrew J.L. Walsh, VenKatesh R. Manda, John Burnes
  • CHIMERIC NATRIURETIC PEPTIDE COMPOSITIONS AND METHODS OF PREPARATION
    Publication number: 20130244937
    Abstract: Therapeutic compositions containing chimeric natriuretic peptides for treating chronic kidney disease alone, heart failure alone, or chronic kidney disease with concomitant heart failure are described. The therapeutic compositions have enhanced stability characteristics to facilitate storage and delivery by provisioning apparatuses under conditions of elevated temperature and mechanical stress. Methods for increasing the stability of therapeutic compositions containing chimeric natriuretic peptides are further described.
    Type: Application
    Filed: September 2, 2012
    Publication date: September 19, 2013
    Applicants: NILE THERAPEUTICS, INC., MEDTRONIC, INC.
    Inventors: William Van Antwerp, Andrew J. L. Walsh, Lian Luo, Dianne L. Judd
  • THERAPY FOR KIDNEY DISEASE AND/OR HEART FAILURE
    Publication number: 20120277155
    Abstract: Medical systems and methods for treating kidney disease alone, heart failure alone, chronic kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a natriuretic peptide such as Vessel Dilator to a subject. Methods for increasing and maintaining peptide levels at a certain concentration include direct peptide delivery via either an external or implantable programmable pump.
    Type: Application
    Filed: February 7, 2012
    Publication date: November 1, 2012
    Applicant: MEDTRONIC, INC.
    Inventors: William P. VanAntwerp, Andrew J. L. Walsh, VenKatesh R. Manda, John Burnes
  • SYSTEMS AND METHODS FOR THERAPY OF KIDNEY DISEASE AND/OR HEART FAILURE USING CHIMERIC NATRIURETIC PEPTIDES
    Publication number: 20120220528
    Abstract: Medical systems and methods for treating kidney disease alone, heart failure alone, kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a chimeric natriuretic peptide to a patient. Methods for increasing peptide levels include direct peptide delivery via either an external or implantable programmable pump.
    Type: Application
    Filed: February 7, 2012
    Publication date: August 30, 2012
    Applicant: MEDTRONIC, INC.
    Inventors: William P. Van Antwerp, VenKatesh R. Manda, Andrew J. L. Walsh, John Burnes, Daron Evans, Hsiao Lieu